Research Says Allergy Medications Can Fight Multiple Sclerosis
Effects of the drug on the group with MS
They found there to be much less visual-evoked potential latency delay in those who had received the clemastine fumarate.
The visual system is considered both one of the earliest and most prominent areas impacted by the condition. This delay is also used to confirm a diagnosis of multiple sclerosis, making it a clear indicator into the efficacy of the drug. Myelin regeneration results in the restoration of neural function, which is why a new study, named the ReBUILD trial, has been started.